You are here

Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Pediatric Psoriasis

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
Centre Hospitalier Victor Dupouy / Service de Dermatologie
Argenteuil Cedex, , 95107 France
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Psoriasis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
6-17 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- 17 years of age or younger

- Diagnosed with plaque psoriasis by a dermatologist.

- Prior to enrollment, there must be a clinical decision to initiate etanercept for the
treatment of plaque psoriasis and etanercept must then be initiated.

- Actively being treated with etanercept, regardless of length of treatment prior to
enrollment

- Willing to provide written informed consent

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Prior therapy with etanercept or other biologic agent

- History of malignancy

NCT01100034
Pfizer
Completed
Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Pediatric Psoriasis

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Psoriasis Vulgaris, Psoriasis Arthropathica, Pustular Psoriasis, Erythrodermic Psoriasis
NCT03885089
All Genders
0+
Years
Tokyo,

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now